search
Back to results

Biotherapies and Therapeutic Education in Chronic Inflammatory Rheumatism (ERIBIO)

Primary Purpose

Rheumatoid Arthritis, Spondyloarthritis

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Therapeutic education
Sponsored by
University Hospital, Clermont-Ferrand
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Rheumatoid Arthritis focused on measuring chronic inflammatory rheumatism, biotherapies, therapeutic education, safety skills

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient age > 18 years old with RA (ACR/EULAR criteria) or SA (ASAS criteria) initiating a first subcutaneous biotherapy.
  • Patient able to complete a questionnaire
  • Patient giving informed consent.
  • Patient covered by social security

Exclusion Criteria:

  • - Patient with disorder of higher mental function or psychiatric disorders.
  • Patient previously treated by intravenous biotherapy.
  • Protected populations: pregnant women, breastfeeding women, tutorship, trusteeship, deprived of liberty, safeguard of justice.

Sites / Locations

  • Chu Clermont-Ferrand

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

interventional group

Control group

Arm Description

M3 (group with 3 to 10 patients) Intensification Biotherapy Education Workshops : "Subcutaneous injection education" and "biotherapy management

M3 (individual) Intensification Biotherapy Education: "Subcutaneous injection education" and "biotherapy management".

Outcomes

Primary Outcome Measures

Change from Baseline Biosecure's score at 6 months after biological treatment initiation
Biosecure questionnaire assesses safety skills regarding infections, vaccinations, and situations of daily life (travel, surgery, pregnancy,…). It's composed of 29 questions about knowledge and 7 scenarios. The response methods are: yes / no / I don't know, with 55 items (score from 0 to 100 points), developed by Therapeutic Education Section of French Society of Rheumatology.

Secondary Outcome Measures

Change from Baseline Biosecure's score at 6 months after biological treatment initiation
Biosecure questionnaire assesses safety skills regarding infections, vaccinations, and situations of daily life (travel, surgery, pregnancy,…). It's composed of 29 questions about knowledge and 7 scenarios. The response methods are: yes / no / I don't know, with 55 items (score from 0 to 100 points), developed by Therapeutic Education Section French Society of Rheumatology.
Number of hospitalizations for infection during the year, collected from patient (tracking book) and in medical file, at the follow-up at M12
patient tracking book includes type of infection, stop biotherapy, consultation with attending physician, taking antibiotics, hospitalization and validation by treating physician
Number of biotherapy stops and number of visits to physician for infection, collected from patient at M6 and M12 (tracking book)
patient tracking book includes type of infection, stop biotherapy, consultation with attending physician, taking antibiotics, hospitalization and validation by treating physician
Type of infections occurring, collected from patient at M6 and M12 (tracking book )
patient tracking book includes type of infection, stop biotherapy, consultation with attending physician, taking antibiotics, hospitalization and validation by treating physician
Coping evaluated by analogical visual scale at M6 and M12
RAID questionnaire is calculated according to 7 numerical rating scales: pain, functional ability, fatigue, sleep, emotional well-being, physical well-being, and disease management. Each scale is evaluated by a number between 0 and 10. A final RAID score with high values characterize a disturbing state of the patient
Psychological well-being evaluated by Analogical visual scale at M6 and M12 by RAID questionnaire.
RAID questionnaire is calculated according to 7 numerical rating scales: pain, functional ability, fatigue, sleep, emotional well-being, physical well-being, and disease management. Each scale is evaluated by a number between 0 and 10. A final RAID score with high values characterize a disturbing state of the patient.
Fear about treatment evaluated by FAIR questionnaire at M6 and M12.
FAIR questionnaire (Fear Assessment in Inflammatory Rheumatic diseases) evaluate the levels of fear (side effects of treatment, disease progress,…) and psychological distress in patients, it be included in clinical trial protocols to measure the impact of specific interventions on psychological distress
Patient satisfaction evaluated with Patient satisfaction questionnaire
Patient satisfaction questionnaire items are: overall satisfaction of education sessions, quality of content in line with expectations, teaching methods and tools used, course flow, quality of the exchange

Full Information

First Posted
January 22, 2019
Last Updated
December 21, 2021
Sponsor
University Hospital, Clermont-Ferrand
Collaborators
French Society of Rheumatology
search

1. Study Identification

Unique Protocol Identification Number
NCT03838939
Brief Title
Biotherapies and Therapeutic Education in Chronic Inflammatory Rheumatism
Acronym
ERIBIO
Official Title
Impact of Association of Individual and Group Therapeutic Education Sessions on the Acquisition of Safety Skills by Patients With Chronic Inflammatory Rheumatism (CIR) Treated With Subcutaneous Biotherapy, Compared to Individual Therapeutic Education Sessions Alone
Study Type
Interventional

2. Study Status

Record Verification Date
December 2021
Overall Recruitment Status
Completed
Study Start Date
January 21, 2019 (Actual)
Primary Completion Date
December 10, 2021 (Actual)
Study Completion Date
December 10, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Clermont-Ferrand
Collaborators
French Society of Rheumatology

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The hypothesis is that group interaction associated with individual interviews intensify the acquisition of safety skills compared to individual interviews alone in patients with CIR treated by subcutaneous biotherapies.
Detailed Description
Selection and inclusion of patients will be done by principal investigator of Rheumatology Department. After verification of inclusion and non-inclusion criteria by principal investigator and signature of consent, patients will be randomized by 1: 1 randomization (centralized randomization by statistician into 2 groups at M0) : Experimental group (individual and group therapeutic education ) M0 (individual) Educational diagnosis and biotherapy education: "subcutaneous injection education" and "biotherapy management". M3 (group with 3 to 10 patients) Intensification Biotherapy Education: Workshops : "Subcutaneous injection education" and "biotherapy management". M6 (individual presential or by phone) Assessment of security skills and questionnaires. M12 (individual presential or by phone) Assessment of security skills and questionnaires. Control group (individual therapeutic education alone ) : M0 (individual) Educational diagnosis and biotherapy education: "subcutaneous injection education" and "biotherapy management". M3 (individual) Intensification Biotherapy Education: "Subcutaneous injection education" and "biotherapy management". M6 (individual présential or by phone) Assessment of security skills and questionnaires. M12 (individual présential or by phone) Assessment of security skills and questionnaires. Group session proposed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rheumatoid Arthritis, Spondyloarthritis
Keywords
chronic inflammatory rheumatism, biotherapies, therapeutic education, safety skills

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
None (Open Label)
Masking Description
no masking
Allocation
Randomized
Enrollment
120 (Actual)

8. Arms, Groups, and Interventions

Arm Title
interventional group
Arm Type
Experimental
Arm Description
M3 (group with 3 to 10 patients) Intensification Biotherapy Education Workshops : "Subcutaneous injection education" and "biotherapy management
Arm Title
Control group
Arm Type
Placebo Comparator
Arm Description
M3 (individual) Intensification Biotherapy Education: "Subcutaneous injection education" and "biotherapy management".
Intervention Type
Other
Intervention Name(s)
Therapeutic education
Intervention Description
Individual and group therapeutic education sessions will consist of : acquisition by patient of self-care skills such as performing subcutaneous injection, acquisition by patient of safety skills such as identifying symptoms that should lead to consult general practitioner, and stop treatment ...
Primary Outcome Measure Information:
Title
Change from Baseline Biosecure's score at 6 months after biological treatment initiation
Description
Biosecure questionnaire assesses safety skills regarding infections, vaccinations, and situations of daily life (travel, surgery, pregnancy,…). It's composed of 29 questions about knowledge and 7 scenarios. The response methods are: yes / no / I don't know, with 55 items (score from 0 to 100 points), developed by Therapeutic Education Section of French Society of Rheumatology.
Time Frame
at 6 months
Secondary Outcome Measure Information:
Title
Change from Baseline Biosecure's score at 6 months after biological treatment initiation
Description
Biosecure questionnaire assesses safety skills regarding infections, vaccinations, and situations of daily life (travel, surgery, pregnancy,…). It's composed of 29 questions about knowledge and 7 scenarios. The response methods are: yes / no / I don't know, with 55 items (score from 0 to 100 points), developed by Therapeutic Education Section French Society of Rheumatology.
Time Frame
at 6 months
Title
Number of hospitalizations for infection during the year, collected from patient (tracking book) and in medical file, at the follow-up at M12
Description
patient tracking book includes type of infection, stop biotherapy, consultation with attending physician, taking antibiotics, hospitalization and validation by treating physician
Time Frame
at 12 months
Title
Number of biotherapy stops and number of visits to physician for infection, collected from patient at M6 and M12 (tracking book)
Description
patient tracking book includes type of infection, stop biotherapy, consultation with attending physician, taking antibiotics, hospitalization and validation by treating physician
Time Frame
at 6 months and 12 months
Title
Type of infections occurring, collected from patient at M6 and M12 (tracking book )
Description
patient tracking book includes type of infection, stop biotherapy, consultation with attending physician, taking antibiotics, hospitalization and validation by treating physician
Time Frame
at 6 months and 12 months
Title
Coping evaluated by analogical visual scale at M6 and M12
Description
RAID questionnaire is calculated according to 7 numerical rating scales: pain, functional ability, fatigue, sleep, emotional well-being, physical well-being, and disease management. Each scale is evaluated by a number between 0 and 10. A final RAID score with high values characterize a disturbing state of the patient
Time Frame
at 6 months and 12 months
Title
Psychological well-being evaluated by Analogical visual scale at M6 and M12 by RAID questionnaire.
Description
RAID questionnaire is calculated according to 7 numerical rating scales: pain, functional ability, fatigue, sleep, emotional well-being, physical well-being, and disease management. Each scale is evaluated by a number between 0 and 10. A final RAID score with high values characterize a disturbing state of the patient.
Time Frame
at 6 months and 12 months
Title
Fear about treatment evaluated by FAIR questionnaire at M6 and M12.
Description
FAIR questionnaire (Fear Assessment in Inflammatory Rheumatic diseases) evaluate the levels of fear (side effects of treatment, disease progress,…) and psychological distress in patients, it be included in clinical trial protocols to measure the impact of specific interventions on psychological distress
Time Frame
at 6 months and 12 months
Title
Patient satisfaction evaluated with Patient satisfaction questionnaire
Description
Patient satisfaction questionnaire items are: overall satisfaction of education sessions, quality of content in line with expectations, teaching methods and tools used, course flow, quality of the exchange
Time Frame
at 12 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient age > 18 years old with RA (ACR/EULAR criteria) or SA (ASAS criteria) initiating a first subcutaneous biotherapy. Patient able to complete a questionnaire Patient giving informed consent. Patient covered by social security Exclusion Criteria: - Patient with disorder of higher mental function or psychiatric disorders. Patient previously treated by intravenous biotherapy. Protected populations: pregnant women, breastfeeding women, tutorship, trusteeship, deprived of liberty, safeguard of justice.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Françoise FAYET
Organizational Affiliation
University Hospital, Clermont-Ferrand
Official's Role
Principal Investigator
Facility Information:
Facility Name
Chu Clermont-Ferrand
City
Clermont-Ferrand
ZIP/Postal Code
63003
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
23972274
Citation
Gossec L, Fautrel B, Flipon E, Lecoq d'Andre F, Marguerie L, Nataf H, Pallot Prades B, Piperno M, Poilverd RM, Rat AC, Sadji F, Sordet C, Thevenot C, Beauvais C. Safety of biologics: elaboration and validation of a questionnaire assessing patients' self-care safety skills: the BioSecure questionnaire. An initiative of the French Rheumatology Society Therapeutic Education section. Joint Bone Spine. 2013 Oct;80(5):471-6. doi: 10.1016/j.jbspin.2012.11.009. Epub 2013 Aug 20.
Results Reference
background
PubMed Identifier
23875718
Citation
Gronning K, Rannestad T, Skomsvoll JF, Rygg LO, Steinsbekk A. Long-term effects of a nurse-led group and individual patient education programme for patients with chronic inflammatory polyarthritis - a randomised controlled trial. J Clin Nurs. 2014 Apr;23(7-8):1005-17. doi: 10.1111/jocn.12353. Epub 2013 Jul 22.
Results Reference
background
PubMed Identifier
18792423
Citation
Homer D, Nightingale P, Jobanputra P. Providing patients with information about disease-modifying anti-rheumatic drugs: Individually or in groups? A pilot randomized controlled trial comparing adherence and satisfaction. Musculoskeletal Care. 2009 Jun;7(2):78-92. doi: 10.1002/msc.141.
Results Reference
background
PubMed Identifier
12502698
Citation
Koev DJ, Tankova TI, Kozlovski PG. Effect of structured group education on glycemic control and hypoglycemia in insulin-treated patients. Diabetes Care. 2003 Jan;26(1):251. doi: 10.2337/diacare.26.1.251. No abstract available.
Results Reference
background

Learn more about this trial

Biotherapies and Therapeutic Education in Chronic Inflammatory Rheumatism

We'll reach out to this number within 24 hrs